- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Trastuzumab emtansine [Kadcyla] 3.0 mg/kg
Total 164 results
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
Bausch Health Americas, Inc.CompletedRheumatoid ArthritisUnited States
-
AO GENERIUMRecruitingMetabolic Diseases | Mucopolysaccharidosis Type IIRussian Federation
-
BioMarin PharmaceuticalTerminatedDuchenne Muscular DystrophyBelgium, Netherlands, France, United Kingdom, Italy
-
aTyr Pharma, Inc.Foundation for Sarcoidosis ResearchCompletedPulmonary SarcoidosisUnited States
-
Regado Biosciences, Inc.CompletedHealthy VolunteerUnited States
-
Jules Bordet InstituteWithdrawnMetastatic HER2-positive Breast Cancer With Brain Metastasis
-
AblynxCompletedRespiratory Syncytial Virus Lower Respiratory Tract InfectionBelgium, Hungary, Israel, Spain, Estonia, Philippines, Thailand, Bulgaria, Poland, Germany, Chile, Colombia, Croatia, Czechia, Latvia, Malaysia, Slovakia
-
M.D. Anderson Cancer CenterGenentech, Inc.; Seagen Inc.RecruitingMetastatic Solid Tumor | Brain MetastasesUnited States
-
Jenny C. Chang, MDGenentech, Inc.; The Methodist Hospital Research InstituteWithdrawnBreast CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Lpath, Inc.CompletedHealthy SubjectsUnited States
-
ReveraGen BioPharma, Inc.National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedDuchenne Muscular DystrophyUnited States, Canada, United Kingdom, Sweden, Australia, Israel
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | HER2 Positive Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
Genentech, Inc.Completed
-
Hoffmann-La RocheTerminatedMetastatic Breast CancerTaiwan, Korea, Republic of, Thailand, Malaysia
-
Genentech, Inc.Completed
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationUnited States, Spain, Korea, Republic of, Taiwan, Italy, Australia, France
-
Hoffmann-La RocheCompletedBreast CancerItaly, Belgium, Canada, United Kingdom, Argentina, Australia, Austria, Brazil, Bulgaria, China, Croatia, Denmark, Dominican Republic, Ecuador, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, Indonesia, Irelan... and more
-
Hoffmann-La RocheCompletedBladder Cancer | Pancreas Cancer | Cholangiocellular CarcinomaSpain, Italy, Netherlands, Slovakia
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Italy, Korea, Republic of, Spain, Germany, Poland, Switzerland
-
Hoffmann-La RocheTerminated
-
Emergent BioSolutionsNational Institutes of Health (NIH)CompletedAnthraxUnited States
-
Medstar Health Research InstituteGenentech, Inc.CompletedLeft Ventricular Function Systolic Dysfunction | HER2 Positive Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu PositiveUnited States
-
Cancer Trials IrelandTerminatedMetastatic Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast CancerIreland, Spain
-
University of MiamiGenentech, Inc.TerminatedBreast Cancer | Metastatic Breast CancerUnited States
-
Genor Biopharma Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Western Regional Medical CenterTerminatedBreast Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Advanced CancerUnited States
-
Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Korea, Republic of, United Kingdom, Germany, Spain, Taiwan, Australia, Canada, Italy
-
Genentech, Inc.Completed
-
Hoffmann-La RocheTerminatedBreast Cancer | Gastric CancerItaly, Argentina, Canada, France, Greece, Portugal, Slovakia, Brazil, Russian Federation, Spain, Germany, Serbia
-
Hoffmann-La RocheCompletedBreast CancerBelgium, Israel, Spain, Sweden, United States, Switzerland, Russian Federation, Czech Republic, France, Canada, Germany, Korea, Republic of, Australia, Hungary, Thailand, United Kingdom, Italy, Brazil, Slovakia, Poland, India, Norway
-
Dana-Farber Cancer InstituteGenentech, Inc.Recruiting
-
MedSIRHoffmann-La RocheActive, not recruitingEarly Breast CancerSpain, Italy, Germany, Bulgaria, Hungary
-
Eisai Inc.BiogenActive, not recruitingAlzheimer's DiseaseUnited States, Canada, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, Spain, Sweden, United Kingdom
-
Hoffmann-La RocheCompleted
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
Genentech, Inc.CompletedMetastatic Breast CancerUnited States
-
Boehringer IngelheimNot yet recruitingMetastatic Breast Cancer | Esophageal Adenocarcinoma | Metastatic Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma
-
PfizerTerminatedMultiple SclerosisUnited States
-
RemeGen Co., Ltd.Completed
-
AM-PharmaCompleted
-
Hoffmann-La RocheCompletedBreast NeoplasmsCanada, United States, France, Korea, Republic of, Spain, Belgium, Germany, Russian Federation, Taiwan, Ukraine
-
Hoffmann-La RocheActive, not recruitingInflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerCanada, Croatia, Spain, Argentina, Mexico, Korea, Republic of, Bosnia and Herzegovina, Brazil, Costa Rica, Turkey, Singapore, Bulgaria, South Africa, India, Peru, Kenya, Chile
-
Hoffmann-La RocheRecruitingBreast CancerKorea, Republic of, United States, Australia, China, Ukraine, Spain, United Kingdom, Turkey, Mexico, Brazil, Austria, Belgium, Denmark, Germany, Greece, Russian Federation, Taiwan, France, Kenya, New Zealand, Portugal, Thailand, Rom... and more
-
Jenny C. Chang, MDThe Methodist Hospital Research InstituteCompletedMetastatic Breast CancerUnited States
-
Population Health Research InstituteRecruitingHeart Failure | Breast CancerCanada, Brazil, Russian Federation